CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
liver biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00701376
NCT00701376N/ACompleted
CompareCT.gov

Long Term Hepatic Effects of Gastric Bypass Surgery

The Cleveland Clinic·interventional·Posted Jun 19, 2008·Updated Jun 19, 2020

In Brief

A clinical study evaluating liver biopsy for Liver Diseases. Completed, enrolled 106 participants across 1 site.

Detailed Summary

Liver disease in the morbidly obese is thought to occur due to the long-term presence of fat deposits in the liver, resulting in inflammation and scarring of the liver over time, which reduces liver function. However, many of these patients are unaware that their liver is damaged. There is currently no consensus regarding what the long-term effects of gastric bypass surgery are on pre-existing liver disease in morbidly obese patients. This study will determine the long-term effects on the liver after this type of surgical procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Diseases
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 19, 2008
Enrollment StartJun 1, 2008
Primary CompletionFeb 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 18.0 years ago

Interventions

liver biopsyother

Subjects undergoing laparoscopic gastric surgery will be evaluated for liver function by comparing liver tissue biopsied during surgery with tissue biopsied after 60% weight loss